Avoro Capital Advisors LLC Ascendis Pharma A/S Transaction History
Avoro Capital Advisors LLC
- $7.32 Billion
- Q3 2025
A detailed history of Avoro Capital Advisors LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 5,110,000 shares of ASND stock, worth $1.04 Billion. This represents 13.88% of its overall portfolio holdings.
Number of Shares
5,110,000
Previous 4,980,000
2.61%
Holding current value
$1.04 Billion
Previous $860 Million
18.19%
% of portfolio
13.88%
Previous 15.67%
Shares
30 transactions
Others Institutions Holding ASND
# of Institutions
318Shares Held
65MCall Options Held
476KPut Options Held
142K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.1 Billion35.1% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.26MShares$1.08 Billion4.77% of portfolio
-
Janus Henderson Group PLC London, X04.32MShares$884 Million0.41% of portfolio
-
Lombard Odier Asset Management (Europe) LTD London, X04.27MShares$873 Million0.89% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$761 Million1.13% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.4B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...